Discordance of Small Dense LDL Cholesterol Beyond LDL Cholesterol or Non-HDL Cholesterol and Carotid Plaque [0.03%]
小而密低密度脂蛋白胆固醇与低密度脂蛋白胆固醇或非高密度脂蛋白胆固醇及颈动脉斑块不一致
Jinqi Wang,Xiaoyu Zhao,Yanchen Zhao et al.
Jinqi Wang et al.
Background: Different low-density lipoprotein (LDL) particles exhibit distinct proatherogenic properties. Objectives: This study sought...
Effects of Mavacamten on Cardiac Magnetic Resonance Features in Chinese Patients With Obstructive Hypertrophic Cardiomyopathy [0.03%]
mavacamten对中国梗阻性肥厚型心肌病患者心血管磁共振特征影响的研究
Zhuang Tian,Liwen Li,Xiaoyan Li et al.
Zhuang Tian et al.
Background: Mavacamten, a first-in-class cardiac myosin inhibitor and the only approved cardiac myosin inhibitor worldwide, improved clinical symptoms and health status in patients with symptomatic obstructive hypertrophi...
Shin-Huei Liu,Tze-Fan Chao
Shin-Huei Liu
Triple Assessments of Atherosclerosis in Patients With Heterozygous Familial Hypercholesterolemia [0.03%]
杂合子家族性高胆固醇血症患者的动脉粥样硬化三重评估指标研究
Hayato Tada,Nobuko Kojima,Kan Yamagami et al.
Hayato Tada et al.
Background: Data on the appropriate timing and impact of atherosclerosis assessment in patients with heterozygous familial hypercholesterolemia (HeFH) are limited. ...
Yoshihiro Miyamoto
Yoshihiro Miyamoto
Arrhythmogenic Cardiomyopathy: Expanding Phenotypic Variability in Different Populations Around the World [0.03%]
遗传性心律失常性心血管病的表型多样性及其在世界各地的不同人群中的异同点
Natalia Olivetti,Luciana Sacilotto,Marcelo Luiz Campos Vieira
Natalia Olivetti
Cardiovascular-Kidney-Metabolic Syndrome in China: A Nationwide Wake-Up Call [0.03%]
中国心血管-肾脏-代谢综合征的全国警示信号
Meihan Guo
Meihan Guo
Transcatheter Aortic Valve Replacement for Pure Aortic Regurgitation: Dedicated Technique or Dedicated Device? [0.03%]
经导管主动脉瓣植入用于单纯性主动脉反流：特设技术还是特设器械？
Vyanne Hei-Tung Chan,Kent Chak-Yu So
Vyanne Hei-Tung Chan
The Long March to Identify Patients With Coronary Artery Disease by Pretest Probability Model [0.03%]
冠心病患者识别的预试验概率模型长路漫漫
Shengxian Tu,Miao Chu
Shengxian Tu
Cardiovascular Implications of Lipoprotein(a) and its Genetic Variants: A Critical Review From the Middle East [0.03%]
脂蛋白(a)及其遗传变异体的心血管影响：来自中东的批判性评论
Ayman El-Menyar,Naushad A Khan,Wael Al Mahmeed et al.
Ayman El-Menyar et al.
Dyslipidemia, a significant risk factor for cardiovascular diseases (CVDs), is prevalent in the Middle East (ME) countries. With a variable prevalence, elevated lipoprotein (a) [Lp(a)] is the most widespread monogenic dyslipidemic disorder....